Glucocil is not a recommended treatment for diabetes, according to the U.S. Food and Drug Administration. On July 15, 2013, in an FDA warning letter to Neuliven Health, the product manufacturer, the agency stated it does not recognize the drug's safety and effectiveness for managing and stabilizing blood glucose levels.
As of 2015, the FDA has not approved Glucocil as a new drug. The agency warns consumers to check with their health care providers before buying suspect diabetes treatment products that make unsubstantiated claims, such as Glucocil. Diabetes patients place themselves at risk of major health complications and expose themselves to danger if they purchase diabetes products sold illegally, notes the FDA.